Status:
COMPLETED
Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Evaluated the effect of perioperative parecoxib administration on postoperative pain, analgesic use, function recovery, inflammatory response and bleeding risk.
Detailed Description
Non-steroid anti-inflammatory drugs are recommended for multimodal postoperative pain management. We evaluated the effect of perioperative parecoxib administration on postoperative pain, analgesic us...
Eligibility Criteria
Inclusion
- Male or female patients who have underwent primary unilateral total knee arthroplasty (TKA) and total hip arthroplasty (THA).
- Age between 18-65 years.
- Chinese ethnicity.
Exclusion
- patients who underwent a reversion or a previous TKA or THA, emergency TKA, or TKA as result of a trauma.
- patient exhibited allergy to parecoxib sodium.
- lactating or pregnant.
- any other conditions not suitable for surgery as evaluated by the surgeon in charge.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT02272660
Start Date
October 1 2014
End Date
August 1 2015
Last Update
August 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100005